Back to search

Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women

Data up to Jan 2025

Published2009
Citations183
References13

Total Citations Per Year

Abstract

References (13)

The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi Jews

1997 • 2,255 citations

A breast cancer prediction model incorporating familial and personal risk factors

2004 • 1,203 citations

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1996 • 762 citations

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

1999 • 390 citations

BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer

2000 • 311 citations

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme

2003 • 304 citations

Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?

2008 • 105 citations

Uptake of clinical genetic testing for ovarian cancer in Ontario: A population-based study

2008 • 51 citations

Colorado family physicians' knowledge of hereditary breast cancer and related practice.

2001 • 45 citations

Swiss primary care physicians' knowledge, attitudes and perception towards genetic testing for hereditary breast cancer

2001 • 40 citations

A rapid fluorescent multiplexed‐PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes

2000 • 34 citations

Evaluation of mathematical models for breast cancer risk assessment in routine clinical use

2007 • 26 citations

Knowledge about breast cancer risk factors and hereditary breast cancer among early-onset breast cancer survivors.

2001 • 15 citations

Cited By (0)

No citing papers found in database

Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women (2009) – Journal of Clinical Oncology | Metascience Observatory Explorer